E6020, a TLR4 Agonist Adjuvant, Enhances Both Antibody Titers and Isotype Switching in Response to Immunization with Hapten-Protein Antigens and Is Diminished in Mice with TLR4 Signaling Insufficiency is a research paper published in The Journal of Immunology (2022). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI125215
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI123371
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: U19-AI082655
NIAID NIH HHS
Grant: R01 AI125215
NIAID NIH HHS
Grant: R01 AI036525
NIAID NIH HHS
Grant: U19 AI142725
NIAID NIH HHS
Grant: R01 AI123371
NIAID NIH HHS
Grant: U19 AI082655
National Institutes of Health
Grant: 5U19AI082655-03
Administration Core
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/CCI-BIO/29266/2017
Deep Drug Discovery and Deployment
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals